Jan H. Schefe

1.8k total citations · 1 hit paper
14 papers, 1.5k citations indexed

About

Jan H. Schefe is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Jan H. Schefe has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Jan H. Schefe's work include Receptor Mechanisms and Signaling (6 papers), Renin-Angiotensin System Studies (4 papers) and Hormonal Regulation and Hypertension (3 papers). Jan H. Schefe is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Renin-Angiotensin System Studies (4 papers) and Hormonal Regulation and Hypertension (3 papers). Jan H. Schefe collaborates with scholars based in Germany, Netherlands and United States. Jan H. Schefe's co-authors include Thomas Unger, Heiko Funke‐Kaiser, Ivo Buschmann, Kerstin Lehmann, Mario Menk, Jana Reinemund, Robin M. Hobbs, Patricia Ruíz, Pier Paolo Pandolfi and Karin Effertz and has published in prestigious journals such as Circulation Research, Brain Research and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Jan H. Schefe

14 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s C T difference” formula

2006 697 citations Jan H. Schefe, Kerstin Lehmann et al. Journal of Molecular Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan H. Schefe Germany	12	770	441	334	138	118	14	1.5k
Heiko Funke‐Kaiser Germany	18	940 1.2×	709 1.6×	469 1.4×	174 1.3×	128 1.1×	29	1.8k
Jie Cui China	21	862 1.1×	297 0.7×	55 0.2×	160 1.2×	135 1.1×	84	1.7k
Alvair P. Almeida Brazil	28	1.0k 1.3×	1.4k 3.1×	764 2.3×	182 1.3×	189 1.6×	59	2.4k
Danielle Château France	24	2.0k 2.6×	298 0.7×	114 0.3×	368 2.7×	178 1.5×	44	2.7k
Paul J. McDermott United States	32	1.6k 2.0×	977 2.2×	77 0.2×	173 1.3×	215 1.8×	80	2.5k
Simone Renner Germany	21	1.0k 1.3×	251 0.6×	274 0.8×	182 1.3×	496 4.2×	43	2.1k
Marc‐Antoine Gillis Canada	25	447 0.6×	774 1.8×	56 0.2×	68 0.5×	110 0.9×	63	1.8k
Daekee Lee South Korea	25	887 1.2×	167 0.4×	177 0.5×	142 1.0×	265 2.2×	66	2.3k
Wendie S. Cohick United States	24	643 0.8×	148 0.3×	973 2.9×	74 0.5×	119 1.0×	55	1.9k

Countries citing papers authored by Jan H. Schefe

Since Specialization

Citations

This map shows the geographic impact of Jan H. Schefe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan H. Schefe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan H. Schefe more than expected).

Fields of papers citing papers by Jan H. Schefe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan H. Schefe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan H. Schefe. The network helps show where Jan H. Schefe may publish in the future.

Co-authorship network of co-authors of Jan H. Schefe

This figure shows the co-authorship network connecting the top 25 collaborators of Jan H. Schefe. A scholar is included among the top collaborators of Jan H. Schefe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan H. Schefe. Jan H. Schefe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Abdel‐Tawab, Mona, et al.. (2022). Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials. European Journal of Hospital Pharmacy. 31(2). 135–142. 1 indexed citations

Liu, Hongyu, Christian Schölz, Chuanbing Zang, et al.. (2012). Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.. PubMed. 32(5). 1627–37. 88 indexed citations

Regierer, Anne C., Nikola Bangemann, Jan H. Schefe, et al.. (2011). Primary Tumor Excision in Stage IV Breast Cancer at Diagnosis without Influence on Survival: A Retrospective Analysis and Review of the Literature. Onkologie. 34(11). 607–612. 15 indexed citations

Seidel, Kerstin, Sebastian Kirsch, Kristin Lucht, et al.. (2010). The Promyelocytic Leukemia Zinc Finger (PLZF) Protein Exerts Neuroprotective Effects in Neuronal Cells and is Dysregulated in Experimental Stroke. Brain Pathology. 21(1). 31–43. 17 indexed citations

Menk, Mario, Clarissa von Haefen, Heiko Funke‐Kaiser, et al.. (2010). Ethanol-induced downregulation of the angiotensin AT2 receptor in murine fibroblasts is mediated by PARP-1. Alcohol. 44(6). 495–506. 9 indexed citations

Reinemund, Jana, Kerstin Seidel, U. Muscha Steckelings, et al.. (2009). Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes. Biochemical Pharmacology. 77(12). 1795–1805. 25 indexed citations

Funke‐Kaiser, Heiko, Frank S. Zollmann, Jan H. Schefe, & Thomas Unger. (2009). Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage. Hypertension Research. 33(2). 98–104. 35 indexed citations

Schefe, Jan H., Thomas Unger, & Heiko Funke‐Kaiser. (2008). PLZF and the (pro)renin receptor. Journal of Molecular Medicine. 86(6). 623–627. 28 indexed citations

Thöne‐Reineke, Christa, Christian Neumann, Pawel Namsolleck, et al.. (2008). The β-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. Journal of Hypertension. 26(12). 2426–2435. 90 indexed citations

10.

Schefe, Jan H., Christian Neumann, Matthias Goebel, et al.. (2008). Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. Journal of Hypertension. 26(9). 1787–1794. 81 indexed citations

11.

Schefe, Jan H., Maxim Krikov, Susanne Müller, et al.. (2008). Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain. Brain Research. 1208. 225–233. 36 indexed citations

12.

Schefe, Jan H., Kerstin Lehmann, Ivo Buschmann, Thomas Unger, & Heiko Funke‐Kaiser. (2006). Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s C T difference” formula. Journal of Molecular Medicine. 84(11). 901–910. 697 indexed citations breakdown →

13.

Schefe, Jan H., Mario Menk, Jana Reinemund, et al.. (2006). A Novel Signal Transduction Cascade Involving Direct Physical Interaction of the Renin/Prorenin Receptor With the Transcription Factor Promyelocytic Zinc Finger Protein. Circulation Research. 99(12). 1355–1366. 254 indexed citations

14.

Wruck, Christoph Jan, Heiko Funke‐Kaiser, Thomas Pufe, et al.. (2004). Regulation of Transport of the Angiotensin AT2 Receptor by a Novel Membrane-Associated Golgi Protein. Arteriosclerosis Thrombosis and Vascular Biology. 25(1). 57–64. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact